U.S. flag

An official website of the United States government

NM_000151.4(G6PC1):c.788del (p.Lys263fs) AND Glycogen storage disease due to glucose-6-phosphatase deficiency type IA

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 5, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002651266.2

Allele description [Variation Report for NM_000151.4(G6PC1):c.788del (p.Lys263fs)]

NM_000151.4(G6PC1):c.788del (p.Lys263fs)

Gene:
G6PC1:glucose-6-phosphatase catalytic subunit 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17q21.31
Genomic location:
Preferred name:
NM_000151.4(G6PC1):c.788del (p.Lys263fs)
HGVS:
  • NC_000017.11:g.42911140del
  • NG_011808.1:g.15343del
  • NM_000151.4:c.788delMANE SELECT
  • NM_001270397.2:c.*180del
  • NP_000142.1:p.Lys263Argfs
  • NP_000142.2:p.Lys263fs
  • LRG_147t1:c.788del
  • LRG_147:g.15343del
  • LRG_147p1:p.Lys263Argfs
  • NC_000017.10:g.41063156del
  • NC_000017.10:g.41063157del
  • NM_000151.2:c.788delA
Protein change:
K263fs
Molecular consequence:
  • NM_001270397.2:c.*180del - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_000151.4:c.788del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA (GSD1A)
Synonyms:
GSD Ia; Glycogen storage disease type 1A; Von Gierke disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009287; MedGen: C2919796; Orphanet: 364; Orphanet: 79258; OMIM: 232200

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003517526Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 5, 2023)
germlineclinical testing

PubMed (8)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Identification of a novel mutation (867delA) in the glucose-6-phosphatase gene in two siblings with glycogen storage disease type Ia with different phenotypes.

Rake JP, ten Berge AM, Visser G, Verlind E, Niezen-Koning KE, Buys CH, Smit GP, Scheffer H.

Hum Mutat. 2000 Apr;15(4):381.

PubMed [citation]
PMID:
10737986

Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus.

Lei KJ, Chen YT, Chen H, Wong LJ, Liu JL, McConkie-Rosell A, Van Hove JL, Ou HC, Yeh NJ, Pan LY, et al.

Am J Hum Genet. 1995 Oct;57(4):766-71.

PubMed [citation]
PMID:
7573034
PMCID:
PMC1801521
See all PubMed Citations (8)

Details of each submission

From Invitae, SCV003517526.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (8)

Description

This sequence change creates a premature translational stop signal (p.Lys263Argfs*38) in the G6PC gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 95 amino acid(s) of the G6PC protein. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with glycogen storage disease (PMID: 10737986). This variant is also known as 867delA. ClinVar contains an entry for this variant (Variation ID: 2197137). This variant disrupts a region of the G6PC protein in which other variant(s) (p.Gln347*) have been determined to be pathogenic (PMID: 7573034, 8182131, 8733042, 10070617, 11949931, 28397058). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024